It paves the way in Ireland for hospitals and clinics to offer it to patients who meet the criteria for using it. Wegovy, or semaglutide, is a repurposed diabetes medication which has been found in trials to lead to obese patients losing an average of three stone. Medications with semaglutide are already licensed for treatment here for diabetes at a lower dose than Wegovy. HSE obesity lead Donal O’Shea has been the strongest advocate for years for more investment in the prevention and treatment of obesity. Last year the HSE launched the Model of Care for the Management of Overweight and Obesity in Ireland.

Source: Irish Independent March 21, 2022 08:48 UTC